Selva Therapeutics: Funding, Investors & Team (Sep 2026)
Selva Therapeutics is a biotechnology company dedicated to the development of therapeutics for infectious diseases.
Selva Therapeutics has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Jul 2020.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Selva Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2020.
Selva Therapeutics Funding Rounds
Selva Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Selva Therapeutics Funding Compared to Other Biotechnology Startups
Selva Therapeutics' latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Selva Therapeutics in Biotechnology and Del Mar
Companies Similar to Selva Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Selva Therapeutics Funding FAQs
What does Selva Therapeutics do?
Selva Therapeutics is a biotechnology company dedicated to the development of therapeutics for infectious diseases.
How much funding has Selva Therapeutics raised?
Selva Therapeutics has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Jul 2020.
When did Selva Therapeutics last raise funding?
Selva Therapeutics' most recent funding round on record is an undisclosed round of $3.0M, announced in Jul 2020.
Who is the CEO of Selva Therapeutics?
Ted Daley is listed as CEO at Selva Therapeutics.
Where is Selva Therapeutics headquartered?
Selva Therapeutics is based in Del Mar, California, United States.
How many employees does Selva Therapeutics have?
Selva Therapeutics is in the 1-10 employee band.
How does Selva Therapeutics' funding compare to other Biotechnology startups?
Selva Therapeutics' latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Selva Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Selva Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.